PDX Portal

Model Details

Patient Information for Model: TCH-AML004

Model Contact

Model: TCH-AML004
Model Contact: Michele Redell
Institution: TCH Leukemia PDX Program
Email: mlredell@texaschildrens.org

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML004

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCH-AML004

There are no histology images for this model.

Metastasis Information for Model: TCH-AML004

Patient

PDX

Central Nervous System

Face

Gingiva

Liver

Lymph node

Orbital chloroma

Retinas

Skin

Spleen

Testis

Tongue

Patient Treatment Information for Model: TCH-AML004

Event Id	Treatment	Treatment Setting	Age at Start	Duration	Clinical Response	Measurable Residual Disease
10	ADE10	De Novo	1.17	1Unknown	Residual Disease	25%
15	ADE8	De Novo	1.25	1Unknown	Residual Disease	2%
30	Vorino/Decitabine/FLAG	Refractory	1.37	1Unknown	Residual Disease	1%
35	Vorino/Decitabine/FLAG	Refractory	1.45	1Unknown	Residual Disease	1%
50	Vyxeos	Refractory	1.54	1Unknown	Residual Disease	8%
60	Enasidanib	Refractory	1.65	1Unknown	Residual Dissease	13%